Corbus Pharmaceuticals Holdings, Inc. — Key Metrics
10 years of history · ending 2023-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-10
Book Value Per Share
$-2
Free Cash Flow Per Share
$-8
Cash Per Share
$3
Revenue Per Share
$-1
OCF Per Share
$-8
Return on Equity↑+82.3pts
-342.0%
Return on Assets↑+54.3pts
-94.3%
Return on Invested Capital↑+192.4pts
-169.3%
Debt to Equity
0.00
Current Ratio↓-32.5% -$0
0.74
Quick Ratio↓-32.5% -$0
0.74
Asset Turnover↓-108.2% -$1
-0.06
R&D / Revenue↓-1313.9pts
-1065.9%
SBC / Revenue↓-151.8pts
-118.7%
Capex / Revenue↓-7.6pts
0.0%
Working Capital↓-355.5% -$12M
$-8M
Net Current Asset Value↓-140.8% -$7M
$-12M
Invested Capital↓-212.1% -$13M
$-7M
OCF / Net Income↑+26.5% +$0
0.81
FCF / Net Income↑+19.3% +$0
0.81
Accruals Ratio (Sloan)↑+22.3pts
-30.1%
Net Debt↑+34.2% +$11M
$-21M
Net Debt / EBITDA↑+13.2% +$0
0.47
Interest Coverage
-11.86
Cash Coverage
-9.50
Capex Coverage↓-21258.4% -$3K
-2791.62
Tangible Common Equity↓-212.1% -$13M
$-7M
TCE / Total Assets↓-37.0pts
-24.4%
NOPAT↑+41.5% +$25M
$-36M
Cash ROIC↑+116.2pts
-171.6%
WC / Revenue↑+276.5pts
285.5%
Capex / D&A↓-100.0% -$4
0.00
Reinvestment Rate↑+4.0pts
1.4%
Asset Growth vs Revenue Growth↑+624.7pts
-20.2%
Revenue 5Y CAGR
-14.3%
Book Value 5Y CAGR
-10.6%
Stock Price (FY-end)↓-96.3% -$158
$6
Market Cap
$26M
P/S Ratio
-8.94
P/B Ratio
0.42
P/TB Ratio
0.42
Enterprise Value
$5M
EV / Sales
-1.79
FCF Yield
-138.1%
Shareholder Yield
-13.3%
R&D Yield
119.2%
Capex Yield
0.0%
Shares Variation (YoY)
3.8%
Beta (5Y)↑+11.6% +$0
1.40
Cost of Equity↑+0.7pts
11.5%
Cost of Debt (after tax)
15.3%
WACC
13.3%
ROIC - WACC Spread
-60.4%
52W High↓-95.5% -$257
$12
52W Low↓-98.3% -$127
$2
Trailing Return 1Y↑+91.2pts
84.7%
Trailing Return 5Y↓-192.3pts
-96.6%
F-Score (Piotroski)↑+0.0% +$0
2.00
Z-Score (Altman)
-26.90
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.